BU35YZZ
Magnetic Resonance Imaging (MRI) Ovaries, Bilateral to None with None, Other Contrast Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | B Imaging |
| Body System | U Female Reproductive System |
| Operation | 3 Magnetic Resonance Imaging (MRI) |
| Body Part | 5 Ovaries, Bilateral |
| Approach | Y Other Contrast |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Computer reformatted digital display of multiplanar images developed from the capture of radiofrequency signals emitted by nuclei in a body site excited within a magnetic field
Procedure Overview
MRI of the female reproductive system creates detailed, multiplanar images of the uterus, ovaries, cervix, and surrounding pelvic tissue using a magnetic field and radio signals rather than X-rays. It is frequently used to characterize an indeterminate ovarian or uterine mass first seen on ultrasound, map the extent of endometriosis, stage gynecologic cancers before treatment, or evaluate congenital uterine anomalies such as a bicornuate uterus.
Because MRI produces excellent soft-tissue contrast without ionizing radiation, it is well suited to distinguishing between tissue types, such as differentiating a fibroid from adenomyosis, in ways that ultrasound alone often cannot resolve. A gadolinium contrast injection may be added when vascular characteristics of a mass need to be assessed, and specialized protocols exist for pelvic staging in oncology.
Anatomy & Axis Detail
Ovaries, Bilateral
Bilateral ovarian MRI is performed when abnormalities are suspected or identified on both sides, as in polycystic ovarian morphology, bilateral endometriomas, or metastatic disease such as Krukenberg tumors, where comparison between the two ovaries informs diagnosis and staging. Imaging both ovaries in the same study allows direct comparison of size, morphology, and enhancement pattern, which is particularly relevant when one ovary's appearance raises suspicion that must be weighed against the contralateral side's baseline characteristics. This bilateral approach is also standard in comprehensive staging of suspected gynecologic malignancy, since involvement of both ovaries changes surgical planning toward bilateral salpingo-oophorectomy rather than a unilateral approach, and MRI's tissue characterization guides that distinction more reliably than ultrasound alone.
Contrast: Other Contrast
Other Contrast captures imaging studies using a contrast medium that is neither high- nor low-osmolar iodinated agent, such as barium sulfate for gastrointestinal studies or gadolinium-based agents for certain applications outside standard MRI classification within this axis. It is used when the contrast administered does not fit the osmolarity-based iodinated categories, distinguishing it from those specific classes and from studies performed with no contrast.
Coding & Documentation
The applicable code depends on the specific structures imaged and whether contrast was administered, both of which must be stated plainly in the radiology report rather than inferred from the clinical indication. Coders should confirm whether the study covered the uterus and ovaries broadly or was a dedicated pelvic MRI protocol, since the anatomic detail documented drives code selection. A recurring mistake is coding contrast administration based on the order placed rather than the completed study, when a scan may have been converted to non-contrast due to renal function concerns or patient factors.
Commonly Confused With
This family is most often confused with ultrasonography of the female reproductive system, the typical first-line study for the same indications; the deciding factor is the modality named in the report, since ultrasound uses sound waves in real time while MRI relies on a magnetic field and produces static, computer-reconstructed images. It can also be confused with CT of the pelvis, which uses ionizing radiation and is generally reserved for different indications, such as acute abdominal pain workups, rather than detailed gynecologic soft-tissue characterization.